The ins and outs of insider trading — part two
In its earlier client update on 4 February 2014, DLA Piper outlined the nature and scope of the insider trading prohibition under the Corporations Act and highlighted the extent of the Australian Securities and Investments Commission’s (ASIC’s) recent activity and success in the prosecution of insider trading and market misconduct offences.
This follow-on article (designed to be read in conjunction with the earlier article) details what types of transactions give rise to a heightened risk of insider trading; highlights the importance of confidentiality and risk management in corporate transaction planning; and provides practical guidance on the ways in which insider trading risks can be managed and how the reputational risk stemming from allegations of insider trading or market misconduct can be managed.
The possible contraventions of the insider trading provisions are many and varied. However, some corporate transactions give rise to a heightened risk, for example a proposed change of control transaction involving a listed entity or a proposed capital raise by a listed entity…
Click on the link below to read the rest of the DLA Piper briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
Health Alert — Julia Clare v Australian Community Pharmacy Authority; Dr Reid v Medical Council of NSW; and more
DLA Piper has released the 22 December 2014 issue of its Health Alert, which focuses on judgments, legislation and reports in the health sector.
The European Court of Justice (CJEU) has handed down a landmark judgment concerning the patentability of stem cells in Europe.
Analysis from The Lawyer
Regulators are ramping up the pressure in the aftermath of recession, leaving firms to compete for compliance and restructuring work
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.